KPV (Lysine-Proline-Valine) 5/10mg

KPV (Lysine-Proline-Valine) 5/10mg
£25.00

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

KPV (Lysine-Proline-Valine)

is a naturally occurring, three-amino-acid peptide (tripeptide) that is a fragment of the alpha-melanocyte-stimulating hormone (

α𝛼-MSH). It is widely studied in research for its potent anti-inflammatoryand immunomodulatory properties. 

 

Mechanism of Action 

KPV is a highly stable and effective anti-inflammatory agent that works locally at the site of inflammation: 

  • NF-kB Inhibition: Its primary mechanism involves blocking the nuclear factor-kappa B (NF-kB) pathway. NF-kB acts as an "on switch" for pro-inflammatory genes and cytokine production.
  • Direct Interaction: KPV can penetrate cell membranes, including the nucleus, to directly inhibit the inflammatory process from within the cell.
  • Immunomodulation: It helps to "turn down" an overactive immune response without globally suppressing the immune system like steroids do. 

 

Potential Benefits and Research Areas 

KPV is primarily available as a "research chemical" and is being investigated for a wide range of inflammatory conditions: 

  • Inflammatory Bowel Disease (IBD): Studies have shown it can reduce inflammation and accelerate healing in models of Crohn's disease and ulcerative colitis.
  • Wound Healing: It significantly speeds up the healing process for skin wounds and has antimicrobial properties.
  • Psoriasis and Dermatitis: Topically applied KPV can reduce skin inflammation associated with conditions like eczema.
  • Cancer Support: Research explores KPV's potential to reduce systemic inflammation associated with cancer growth or chemotherapy side effects. 

 

Administration and Status 

  • Methods: KPV is versatile and can be administered in multiple ways:
    • Subcutaneous Injection: Common for systemic or localized effects.
    • Oral/Sublingual: Can be taken orally, often in capsules or dissolved under the tongue.
    • Topical/Transdermal: Applied directly to the skin or in creams for local skin conditions.
  • FDA Status: KPV is not an FDA-approved medication for human use outside of clinical research settings.
  • Safety: Generally considered very safe with low toxicity, even at high doses in animal studies. Side effects are minimal, usually limited to mild injection site reactions. 

Warning: KPV is sold legally as a research chemical intended for laboratory use only. The long-term safety data in humans is not extensive. Always consult a qualified healthcare professional before considering any form of peptide therapy.